Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Koppensteiner

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
VASA. Supplementum|January 1, 1988
[Percutaneous transluminal angioplasty of subclavian stenoses]A Ahmadi, H Ehringer, E Minar, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 16, 2011
On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplastyB van der Loo, J Braun, R Koppensteiner
VASA. Zeitschrift Fur Gefasskrankheiten|April 6, 2004
[How do blood vessels age? Mechanisms and clinical implications]B van der Loo, R Koppensteiner, T F Lüscher
VASA. Supplementum|January 1, 1991
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose]E Minar, R Ahmadi, R Koppensteiner, et al.
Thrombosis and Haemostasis|October 22, 1990
D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive diseaseR Koppensteiner, W Speiser, E Minar, et al.
VASA. Supplementum|January 1, 1990
[Percutaneous transluminal angioplasty of subclavian stenoses]A Ahmadi, E Minar, R Koppensteiner, et al.
Thrombosis Research|November 1, 1988
Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive diseaseE Minar, H Ehringer, M Jung, et al.
VASA. Supplementum|January 1, 1990
[Hemorheologic findings in patients with heart valve replacement]R Koppensteiner, A Moritz, W Schlick, et al.
Radiology|September 1, 1988
Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteriesR Koppensteiner, E Minar, R Ahmadi, et al.
Acta Anaesthesiologica Scandinavica|January 29, 2005
Pentoxifylline attenuates the increase in whole blood viscosity after transfusionA Bacher, E Eggensperger, R Koppensteiner, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
VASA. Supplementum|January 1, 1988
[Percutaneous transluminal angioplasty of subclavian stenoses]A Ahmadi, H Ehringer, E Minar, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 16, 2011
On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplastyB van der Loo, J Braun, R Koppensteiner
VASA. Zeitschrift Fur Gefasskrankheiten|April 6, 2004
[How do blood vessels age? Mechanisms and clinical implications]B van der Loo, R Koppensteiner, T F Lüscher
VASA. Supplementum|January 1, 1991
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose]E Minar, R Ahmadi, R Koppensteiner, et al.
Thrombosis and Haemostasis|October 22, 1990
D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive diseaseR Koppensteiner, W Speiser, E Minar, et al.
VASA. Supplementum|January 1, 1990
[Percutaneous transluminal angioplasty of subclavian stenoses]A Ahmadi, E Minar, R Koppensteiner, et al.
Thrombosis Research|November 1, 1988
Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive diseaseE Minar, H Ehringer, M Jung, et al.
VASA. Supplementum|January 1, 1990
[Hemorheologic findings in patients with heart valve replacement]R Koppensteiner, A Moritz, W Schlick, et al.
Radiology|September 1, 1988
Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteriesR Koppensteiner, E Minar, R Ahmadi, et al.
Acta Anaesthesiologica Scandinavica|January 29, 2005
Pentoxifylline attenuates the increase in whole blood viscosity after transfusionA Bacher, E Eggensperger, R Koppensteiner, et al.
Pageof 9